不同培养条件下透析液和反渗水微生物监测的比较分析

doi:10.3969/j.issn.1673-8640.2015.05.017

摘要/Abstract

摘要： 目的比较不同培养基、孵育温度及培养时间的选择对透析液和反渗水微生物监测总菌落计数的差异,确认透析液和反渗水微生物监测的最佳培养条件。方法采用无菌透析液和无菌反渗水配置模拟污染水样本,倾注法接种于伊红美蓝琼脂(EMB)、大豆酪蛋白琼脂(TSA)、胰蛋白胨葡萄糖浸液(TGEA)培养基,于25℃和35℃分别进行培养,并记录培养48、72 h及7 d的生长情况。结果不论是25℃还是35℃,TGEA的生长情况均最佳且最接近预期菌落数(P<0.05);各种培养基培养72 h比48 h生长好(P<0.05);培养7 d后的菌落数与培养72 h比较差异无统计学意义(P>0.05)。结论使用倾注平板法及TGEA培养基对透析液和反渗水进行微生物监测,需同时在25℃及35℃条件下培养至少72 h,方可产生有效的监测报告,确保患者的透析安全。

关键词: 血液透析液, 反渗水, 总菌落数计算

Abstract: Objective To compare the difference between media, incubation temperatures and culture times on the choice of hemodialysate and reverse osmosis water for microbiological monitoring of heterotrophic plate count, and further to confirm the best culture method of microbiological monitoring for hemodialysate and reverse osmosis. Methods The polluted samples were simulated by using sterile dialysate and sterile reverse osmosis water, and then were incubated in 25℃ and 35℃ with eosin methylene blue agar(EMB), tryptone soy agar(TSA) and tryptone glucose extract agar(TGEA)for 48 h, 72 h and 7 d, respectively. Results Either on 25℃ or 35℃, the bacteria's growth condition in TGEA was better than those under other conditions(P<0.05). The colony numbers of 72 h incubation were more than those of 48 h incubation in all media(P<0.05). However, there was no statistical significance of colony numbers between 7 d incubation and 72 h incubation(P > 0.05). Conclusions The microbiological monitoring for hemodialysate and reverse osmosis water needs to use pour plate method with TGEA, incubating in 25℃ and 35℃ for 72 h, which may provide the effective reports for ensuring the safety of hemodialysis patients.

Key words: Hemodialysate, Reverse osmosis water, Heterotrophic plate count

中图分类号:

R446.11

周悦昌, 任丽娜, 王旭辉, 陈建文, 陈妙佩, 毛鸿忠, 韩立杰. 不同培养条件下透析液和反渗水微生物监测的比较分析[J]. 检验医学, 2015, 30(5): 478-483.

ZHOU Yuechang, REN Lina, WANG Xuhui, CHEN Jianwen, CHEN Miaopei, MAO Hongzhong, HAN Lijie. Comparison analysis of microbiological monitoring between hemodialysate and reverse osmosis water under different media[J]. Laboratory Medicine, 2015, 30(5): 478-483.

图/表 6

参考文献 25

[1]	CANAU B, BOSC JY, LERAY H, et al.Microbiological purity of dialysate for on-line substitution fluid preparation[J]. Nephrol Dial Transplant, 2000, 15(Suppl 2):21-30.
[2]	TATTERSALL JE,WARD RA, EUDIAL Group.Online haemodiafiltration:definition, dose quantification and safety revisited[J]. Nephrol Dial Transplant,2013,28(3): 542-550.
[3]	魏媛媛, 马迎春. 透析用水及透析液的微生物检测[J]. 中国血液净化,2014,13(4):335-339.
[4]	WARD DM. Hemodialysis water: an update on safety issues, monitoring,adverse clinical events[J]. ASAIO J,2004,50(6): Ⅹⅲ-Ⅹⅷ.
[5]	林明滢,王复德,王永卫.不同培养基测定菌落总数的比较[J].感控杂志,2001,11(5):289-298.
[6]	REASONER DJ.Heterotrophic plate count methodology in the United States[J]. Int J Food Microbiol,2004,92(3):307-315.
[7]	NYSTRAND R.Microbiology of water and fluids for hemodialysis[J]. J Chin Med Assoc,2008,71(5):223-229.
[8]	PONTORIERO G, POZZONI P, ANDRULLI S, et al. The quality of dialysis water[J]. Nephrol Dial Transplant,2003,18(Suppl 7): ⅶ21-ⅶ25.
[9]	SMEETS E, KOOMAN J, VAN DER SANDE F, et al. Prevention of biofilm formation in dialysis water treatment systems[J]. Kidney Int,2003,63(4):1574-1576.
[10]	RAY J.Microbiological monitoring of dialysis water systems-which culture method[J]. J Ren Care,2007,33(2):66-69.
[11]	JAMES R.Monitoring of dialysis water systems-is there a need for increased sampling[J]. EDTNA ERCA J,2006,32(2):74-77.
[12]	NYSTRAND R.The microbial world and fluids in dialysis[J]. Biomed Instrum Technol,2008,42(2):150-159.
[13]	JACKSON RW, OSBORNE K, BARNES G,et al.Multiregional evaluation of the SimPlate heterotrophic plate count method compared to the standard plate count agar pour plate method in water[J]. Appl Environ Microbiol,2000,66(1):453-454.
[14]	叶纯宜,林明滢,陈小妮,等.紫外线杀菌效能探讨[J].感控杂志,2005,15(5):293-300.
[15]	ROTH VR, JARVIS WR.Outbreaks of infection and/or pyrogenic reactions in dialysis patients[J]. Semin Dial,2000,13(2):92-96.
[16]	LEDEBO I, BLANKESTIJN PJ.Haemodiafiltration-optimal efficiency and safety[J]. NDT Plus,2010,3(1):8-16.
[17]	ASCI G, TZ H, OZKAHYA M, et al.The impact of membrane permeability and dialysate purity on cardiovascular outcomes[J]. J Am Soc Nephrol,2013,24(6):1014-1023.
[18]	NYSTRAND R.Official recommendations for quality of fluids in dialysis-the need for standardisation[J]. J Ren Care,2009,35(2): 74-81.
[19]	AMATO RL.Water treatment for hemodialysis--updated to include the latest AAMI standards for dialysate(RD52: 2004) continuing[J]. Nephrol Nurs J, 2005,32(2):151-167.
[20]	LAYMAN-AMATO R, CURTIS J, PAYNE GM.Water treatment for hemodialysis: an update[J]. Nephrol Nurs J,2013,40(5):383-404.
[21]	FENDLEY DA, WARD RA.Dialysate quality: new standards require a new approach to compliance[J]. Semin Dial,2012,25(5):510-515.
[22]	KAWASAKI T, UCHINO J, SHINODA T, et al.Guidance of technical management of dialysis water and dialysis fluid for the Japan Association for Clinical Engineering Technologists[J]. Blood Purif,2009,27(Suppl 1):41-49.
[23]	KAWANISHI H, MASAKANE I, TOMO T.The new standard of fluids for hemodialysis in Japan[J]. Blood Purif,2009,27(Suppl 1):5-10.
[24]	KAWANISHI H, AKIBA T, MASAKANE I, et al.Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008[J].Ther Apher Dial,2009,13(2):161-166.
[25]	WARD RA.New AAMI standards for dialysis fluids[J]. Nephrol News Issues,2011,25(13):33-36.